Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Invasive Breast Carcinoma”

617 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 617 results

Testing effectiveness (Phase 2)Study completedNCT03947151
What this trial is testing

Efficacy and Tolerance of an Ovarian Stimulation Protocol Combining Follicle Stimulating Hormone (FSH) and Degarelix Acetate in Female Candidates for Fertility Preservation Before Chemotherapy for Breast Cancer

Who this might be right for
Invasive Ductal Breast Carcinoma
Assistance Publique - Hôpitaux de Paris 8
Not applicableUnknownNCT04937309
What this trial is testing

Efficacy and Safety of Non Invasive Vagal Stimulation to Prevent Chemotherapy-induced Nausea

Who this might be right for
Breast Cancer
University Hospital, Tours 338
Testing effectiveness (Phase 2)UnknownNCT01088893
What this trial is testing

Everolimus in Breast Cancer Patients After Pre-operative Chemotherapy

Who this might be right for
Breast Neoplasms
Organisation for Oncology and Translational Research 50
Not applicableStudy completedNCT00182728
What this trial is testing

Radiation Therapy During Surgery in Treating Older Women With Invasive Breast Cancer

Who this might be right for
Breast Cancer
UNC Lineberger Comprehensive Cancer Center 89
Testing effectiveness (Phase 2)Looking for participantsNCT04115306
What this trial is testing

Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Phoenix Molecular Designs 61
Testing effectiveness (Phase 2)Study completedNCT03188393
What this trial is testing

Assessing the Accuracy of Tumor Biopsies After Chemotherapy to Determine if Patients Can Avoid Breast Surgery

Who this might be right for
Invasive Breast CarcinomaStage II Breast CancerStage IIA Breast Cancer+2 more
NRG Oncology 105
Large-scale testing (Phase 3)Active Not RecruitingNCT03595592
What this trial is testing

Neoadjuvant Treatment of HER2 Positive Early High-risk and Locally Advanced Breast Cancer

Who this might be right for
Invasive Breast Cancer
Fondazione Michelangelo 650
Early research (Phase 1)Looking for participantsNCT04521764
What this trial is testing

A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Invasive Breast CarcinomaMetastatic Breast Adenocarcinoma+2 more
Mayo Clinic 54
Not applicableStudy completedNCT01880645
What this trial is testing

Selective Image Guided Resection of Axillary Lymph Nodes

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 17
Large-scale testing (Phase 3)UnknownNCT00516425
What this trial is testing

Doxorubicin or Epirubicin and Cyclophosphamide in Treating Older Women With Invasive Breast Cancer

Who this might be right for
Breast Cancer
Charing Cross Hospital 1,000
Not applicableStudy completedNCT00898508
What this trial is testing

Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease

Who this might be right for
Breast Cancer
City of Hope Medical Center 563
Very early researchActive Not RecruitingNCT04648904
What this trial is testing

Study of a Shortened Radiation Therapy Schedule in People With Breast Cancer

Who this might be right for
Invasive Breast CancerPost-mastectomy
Memorial Sloan Kettering Cancer Center 71
Not applicableStudy completedNCT00569049
What this trial is testing

Molecular Analysis of Breast Cancer

Who this might be right for
Breast CancerBreast Cancer Non-invasive Breast CancerBreast Cancer Early Stage Breast Cancer (Stage 1-3)
Stanford University 788
Post-approval studies (Phase 4)Study completedNCT01176916
What this trial is testing

Aromasin® Interventional Study Of Early Invasive Breast Cancer Patients In China

Who this might be right for
Breast Neoplasms
Pfizer 564
Testing effectiveness (Phase 2)Active Not RecruitingNCT04569747
What this trial is testing

A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer

Who this might be right for
HER2-positive Breast CancerInvasive Carcinoma of the BreastBreast Cancer+3 more
Dana-Farber Cancer Institute 393
Testing effectiveness (Phase 2)Study completedNCT00019500
What this trial is testing

Raloxifene in Preventing Breast Cancer in Premenopausal Women

Who this might be right for
Breast Cancer
National Cancer Institute (NCI)
Not applicableLooking for participantsNCT06328465
What this trial is testing

FREEDOM: REsonance for Early Detection Of Breast Cancer Metastases

Who this might be right for
Invasive Breast CancerHER2-positive Breast CancerTriple Negative Breast Cancer
European Institute of Oncology 145
Testing effectiveness (Phase 2)Active Not RecruitingNCT04551495
What this trial is testing

Neoadjuvant Study of Targeting ROS1 in Combination With Endocrine Therapy in Invasive Lobular Carcinoma of the Breast (ROSALINE)

Who this might be right for
Invasive Lobular Breast CarcinomaER+ Breast CancerHER2-negative Breast Cancer
Jules Bordet Institute 65
Testing effectiveness (Phase 2)Active Not RecruitingNCT03344965
What this trial is testing

Olaparib In Metastatic Breast Cancer

Who this might be right for
Metastatic Breast CancerInvasive Breast CancerSomatic Mutation Breast Cancer (BRCA1)+7 more
Beth Israel Deaconess Medical Center 114
Testing effectiveness (Phase 2)Active Not RecruitingNCT01203839
What this trial is testing

Partial Breast Irradiation (PBI) Using 40 Gy for Select Patients With Early Invasive or Noninvasive Breast Cancer

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 110
Load More Results